Sodium Carbonate

Summary

Sodium Carbonate (CHEMBL186314) is an approved small molecule.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• Chemistry: 105.988 Da · CNa2O3

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL186314
Name	Sodium Carbonate
Type	Small molecule
Max phase	4
FDA approved	yes
PubChem CID	10340
ChEBI	CHEBI:29377
Molecular formula	CNa2O3
Molecular weight	105.988
InChIKey	CDBYLPFSWZWCQE-UHFFFAOYSA-L

SMILES: C(=O)([O-])[O-].[Na+].[Na+]

IUPAC name: disodium;carbonate

Also known as: Anhydrous sodium carbonate, Carbonic acid sodium salt (1:2), Carbonic acid, disodium salt, Dried sodium carbonate, E-500(I), INS NO.500(I), INS-500(I), Natrum carbonicum, NSC-156204, Soda ash, Soda-ash

Patent coverage: 423,142 distinct patent families (1,000,142 SureChEMBL compound mentions), from 1 matched compound structure(s). Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indications (0 at ChEMBL trial phase 4).

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).